HIV-related neurocognitive impairment in the HAART era

Current HIV/AIDS Reports

Volumn 6, Issue 3, 2009, Pages 146-152

  Robinson Papp, Jessica ^a   Elliott, Kathryn J ^b   Simpson, David M ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

BEHAVIOR THERAPY; BEHAVIORAL SCIENCE; BRAIN DAMAGE; BRAIN INFECTION; CD4 LYMPHOCYTE COUNT; COGNITIVE DEFECT; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NEUROCOGNITIVE IMPAIRMENT; NEUROIMAGING; REVIEW; VIRUS LOAD;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BEHAVIOR THERAPY; BIOLOGICAL MARKERS; BRAIN; COGNITION DISORDERS; HIV INFECTIONS; HUMANS; NEUROPSYCHOLOGICAL TESTS;

EID: 67651241749     PISSN: 15483568     EISSN: 15483576     Source Type: Journal    
DOI: 10.1007/s11904-009-0020-1     Document Type: Review

References (45)

1. E.A. Childs R.H. Lyles O.A. Selnes 1999 Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy Neurology 52 607 613
2. N.C. Sacktor R.H. Lyles R.L. Skolasky 1999 Combination antiretroviral therapy improves psychomotor speed performance in HIV-seropositive homosexual men. Multicenter AIDS cohort study (MACS) Neurology 52 1640 1647
3. W.D. Snider D.M. Simpson S. Nielsen 1983 Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients Ann Neurol 14 403 418
4. B.A. Navia B.D. Jordan R.W. Price 1986 The AIDS dementia complex: I. Clinical features Ann Neurol 19 517 524
5. B.A. Navia E.S. Cho C.K. Petito R.W. Price 1986 The AIDS dementia complex: II. Neuropathology Ann Neurol 19 525 535
6. R.W. Price B.J. Brew 1988 The AIDS dementia complex J Infect Dis 158 1079 1083
7. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a working group of the American Academy of Neurology AIDS task force. Neurology 1991, 41:778-785.
8. A. Antinori G. Arendt J.T. Becker 2007 Updated research nosology for HIV-associated neurocognitive disorders Neurology 69 1789 1799
9. J. Robinson-Papp D. Byrd M.R. Mindt 2008 Motor function and human immunodeficiency virus-associated cognitive impairment in a highly active antiretroviral therapy-era cohort Arch Neurol 65 1096 1101
10. N.R. Holland C. Power V.P. Mathews 1994 Cytomegalovirus encephalitis in acquired immunodeficiency syndrome (AIDS) Neurology 44 507 514
11. S.L. Letendre J.A. McCutchan M.E. Childers 2004 Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders Ann Neurol 56 416 423
12. N. Butters I. Grant J. Haxby 1990 Assessment of AIDS-related cognitive changes: recommendations of the NIMH workshop on neuropsychological assessment approaches J Clin Exp Neuropsychol 12 963 978
13. C.L. Carey S.P. Woods J.D. Rippeth 2004 Initial validation of a screening battery for the detection of HIV-associated cognitive impairment Clin Neuropsychol 18 234 248
14. C. Power O.A. Selnes J.A. Grim J.C. McArthur 1995 HIV dementia scale: a rapid screening test J Acquir Immune Defic Syndr Hum Retrovirol 8 273 278
15. E.E. Morgan S.P. Woods J.C. Scott 2007 Predictive validity of demographically adjusted normative standards for the HIV dementia scale J Clin Exp Neuropsychol 20 1 8
16. K.A. Bottiggi J.J. Chang F.A. Schmitt 2007 The HIV dementia scale: predictive power in mild dementia and HAART J Neurol Sci 260 11 15
17. N.C. Sacktor M. Wong N. Nakasujja 2005 The international HIV dementia scale: a new rapid screening test for HIV dementia AIDS 19 1367 1374
18. H.J. von Giesen B.A. Haslinger S. Rohe 2005 HIV dementia scale and psychomotor slowing-the best methods in screening for neuro-AIDS J Neuropsychiatry Clin Neurosci 17 185 191
19. T. Ernst L. Chang J. Jovicich 2002 Abnormal brain activation on functional MRI in cognitively asymptomatic HIV patients Neurology 59 1343 1349
20. A.C. Roc B.M. Ances S. Chawla 2007 Detection of human immunodeficiency virus induced inflammation and oxidative stress in lenticular nuclei with magnetic resonance spectroscopy despite antiretroviral therapy Arch Neurol 64 1249 1257
21. D.A. Rottenberg J.J. Sidtis S.C. Strother 1996 Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementia J Nucl Med 37 1133 1141
22. G.J. Harris G.D. Pearlson J.C. McArthur 1994 Altered cortical blood flow in HIV-seropositive individuals with and without dementia: a single photon emission computed tomography study AIDS 8 495 499
23. B.J. Brew L. Pemberton P. Cunningham M.G. Law 1997 Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage J Infect Dis 175 963 966
24. J.C. McArthur D.R. McClernon M.F. Cronin 1997 Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain Ann Neurol 42 689 698
25. R.W. Price B. Brew J. Sidtis 1988 The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex Science 239 586 592
26. E.A. Murray D.M. Rausch J. Lendvay 1992 Cognitive and motor impairments associated with SIV infection in rhesus monkeys Science 255 1246 1249
27. M.R. Weed R.D. Hienz J.V. Brady 2003 Central nervous system correlates of behavioral deficits following simian immunodeficiency virus infection J Neurovirol 9 452 464
28. J.C. McArthur M.P. McDermott D. McClernon 2004 Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy Arch Neurol 61 1687 1696
29. B.J. Brew R.B. Bhalla M. Paul 1992 Cerebrospinal fluid beta 2-microglobulin in patients with AIDS dementia complex: an expanded series including response to zidovudine treatment AIDS 6 461 465
30. R.W. Price L.G. Epstein J.T. Becker 2007 Biomarkers of HIV-1 CNS infection and injury Neurology 69 1781 1788
31. M.P. Heyes R.J. Ellis L. Ryan 2001 Elevated cerebrospinal fluid quinolinic acid levels are associated with region-specific cerebral volume loss in HIV infection Brain 124 1033 1042
32. M. Gisslen L. Hagberg L. Rosengren 2007 Defining and evaluating HIV-related neurodegenerative disease and its treatment targets: a combinatorial approach to use of cerebrospinal fluid molecular biomarkers J Neuroimmune Pharmacol 2 112 119
33. A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment. Dana consortium on the therapy of HIV dementia and related cognitive disorders. Neurology 1998, 50:645-651.
34. G. Schifitto J. Zhang S.R. Evans 2007 A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment Neurology 69 1314 1321 (Pubitemid 47482445)
35. G. Schifitto B.A. Navia C.T. Yiannoutsos 2007 Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study AIDS 21 1877 1886
36. Safety and tolerability of the antioxidant OPC-14117 in HIV-associated cognitive impairment. The Dana consortium on the therapy of HIV dementia and related cognitive disorders. Neurology 1997, 49:142-146.
37. D.B. Clifford J.C. McArthur G. Schifitto 2002 A randomized clinical trial of CPI-1189 for HIV-associated cognitive-motor impairment Neurology 59 1568 1573
38. G. Schifitto D.R. Peterson J. Zhong 2006 Valproic acid adjunctive therapy for HIV-associated cognitive impairment: a first report Neurology 66 919 921
39. P.N. Heseltine K. Goodkin J.H. Atkinson 1998 Randomized double-blind placebo-controlled trial of peptide T for HIV-associated cognitive impairment Arch Neurol 55 41 51
40. S.C. Follstaedt S.A. Barber M.C. Zink 2008 Mechanisms of minocycline-induced suppression of simian immunodeficiency virus encephalitis: inhibition of apoptosis signal-regulating kinase 1 J Neurovirol 14 376 388
41. R.S. Doody J.C. Stevens C. Beck 2001 Practice parameter: management of dementia (an evidence-based review). Report of the quality standards subcommittee of the American Academy of Neurology Neurology 56 1154 1166
42. W.A. Ray C.P. Chung K.T. Murray 2009 Atypical antipsychotic drugs and the risk of sudden cardiac death N Engl J Med 360 225 235
43. J.L. Bernat 2001 Plan ahead: how neurologists can enhance patient-centered medicine Neurology 56 144 145
44. D.S. Knopman S.T. DeKosky J.L. Cummings 2001 Practice parameter: diagnosis of dementia (an evidence-based review). Report of the quality standards subcommittee of the American Academy of Neurology Neurology 56 1143 1153
45. R.A. Shippy S.E. Karpiak 2005 The aging HIV/AIDS population: fragile social networks Aging Ment Health 9 246 254